You are here » Home » Companies » Company Overview » Everest Organics Ltd

Everest Organics Ltd.

BSE: 524790 Sector: Health care
NSE: N.A. ISIN Code: INE334C01029
BSE LIVE 19:40 | 19 Oct 153.95 6.55
(4.44%)
OPEN

145.00

HIGH

154.75

LOW

145.00

NSE 05:30 | 01 Jan Stock Is Not Traded.
OPEN 145.00
PREVIOUS CLOSE 147.40
VOLUME 1744
52-Week high 154.75
52-Week low 44.45
P/E 74.37
Mkt Cap.(Rs cr) 123
Buy Price 0.00
Buy Qty 0.00
Sell Price 153.95
Sell Qty 29.00
OPEN 145.00
CLOSE 147.40
VOLUME 1744
52-Week high 154.75
52-Week low 44.45
P/E 74.37
Mkt Cap.(Rs cr) 123
Buy Price 0.00
Buy Qty 0.00
Sell Price 153.95
Sell Qty 29.00

Everest Organics Ltd. (EVERESTORGANICS) - Company History

Everest Organics was incorporated at Hyderabad in Feb.'93. It was promoted by S K Srihari Raju and S K Chittiramabhadra Raju. The company set up a plant at Aroor, Andhra Pradesh to manufacture bulk drugs and formulations. It came out with a public issue in Jan.'95 to part-finance the project. Commercial production of ciprofloxacin and omerprazole commenced in Feb.'96. The company preferred to manufacture para hydroxy phynyl glycin (PHPG), but due to market conditions, it decided to drop manufacturing of PHPG and has decided to enhance the capacity of ciprofloxacin from 30 tpa to 120 tpa and also to manufacture enrofloxacin/naproxen. The company has increased its installed capacity of Benzimidazole by 60 tpa there by taking its capacity to 120 tpa.The installed capacity of Omeprazole Op Sulphide was increased from 15 TPA to 30 TPA.